Close
Nordic 9Nordic 9

Leafy Tunnel (investor - Venture Capital)

United Kingdom leafytunnel.com
See something wrong or missing? Let us know
Offices:Wimbledon

Leafy Tunnel is a British early-stage venture capital firm investing in alternative medicine to address mental health and pain disorders.

Average round investment:32M USD
Average number per year:1.0
Distribution: 2023 (1)2022 (1)2021 (1)
Portfolio companies: Denmark Tetra PharmUnited Kingdom Lyphe groupUnited Kingdom Beckley Psytech
Mostly invests in: United Kingdom United Kingdom (2) Manufacturing (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Leafy Tunnel

Name Criteria
Japan Asahi Kasei
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Roche Venture Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Germany PS Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Invus
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
France AXA IM
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Agriculture
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Denmark Lundbeckfond Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Denmark Maj Invest
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Switzerland SkyViews Life Science
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Agriculture
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Denmark Sunstone Life Science Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Palo Santo
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top